These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1091 related items for PubMed ID: 27355131
1. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis. Xu L, Shen P, Bi Y, Chen J, Xiao Z, Zhang X, Wang Z. Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131 [Abstract] [Full Text] [Related]
2. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways. Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Am J Physiol Renal Physiol; 2017 Aug 01; 313(2):F414-F422. PubMed ID: 28566504 [Abstract] [Full Text] [Related]
3. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway. Kolati SR, Kasala ER, Bodduluru LN, Mahareddy JR, Uppulapu SK, Gogoi R, Barua CC, Lahkar M. Environ Toxicol Pharmacol; 2015 Mar 01; 39(2):690-9. PubMed ID: 25704036 [Abstract] [Full Text] [Related]
4. Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structure. Yin D, Yin J, Yang Y, Chen S, Gao X. J Ethnopharmacol; 2014 Mar 01; 151(1):667-74. PubMed ID: 24269771 [Abstract] [Full Text] [Related]
5. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Ji X, Li C, Ou Y, Li N, Yuan K, Yang G, Chen X, Yang Z, Liu B, Cheung WW, Wang L, Huang R, Lan T. Mol Cell Endocrinol; 2016 Dec 05; 437():268-279. PubMed ID: 27378149 [Abstract] [Full Text] [Related]
6. Protective effects of Danshen injection against erectile dysfunction via suppression of endoplasmic reticulum stress activation in a streptozotocin-induced diabetic rat model. Zhang Y, Chen J, Ji H, Xiao ZG, Shen P, Xu LH. BMC Complement Altern Med; 2018 Dec 27; 18(1):343. PubMed ID: 30587186 [Abstract] [Full Text] [Related]
7. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway. Song Y, Liu W, Tang K, Zang J, Li D, Gao H. J Diabetes Res; 2020 Dec 27; 2020():9481720. PubMed ID: 32076626 [Abstract] [Full Text] [Related]
8. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM. J Ethnopharmacol; 2015 Sep 15; 173():256-65. PubMed ID: 26226437 [Abstract] [Full Text] [Related]
9. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway. Zhang H, Yang Y, Wang Y, Wang B, Li R. Drug Des Devel Ther; 2018 Sep 15; 12():89-98. PubMed ID: 29386886 [Abstract] [Full Text] [Related]
10. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats. Mahfoz AM, El-Latif HA, Ahmed LA, Hassanein NM, Shoka AA. Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec 15; 389(12):1315-1324. PubMed ID: 27612855 [Abstract] [Full Text] [Related]
11. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Kuo CW, Shen CJ, Tung YT, Chen HL, Chen YH, Chang WH, Cheng KC, Yang SH, Chen CM. Life Sci; 2015 Aug 15; 135():77-86. PubMed ID: 26006040 [Abstract] [Full Text] [Related]
12. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats. Chen J, Hu Y, Mou X, Wang H, Xie Z. Life Sci; 2021 Jan 15; 265():118835. PubMed ID: 33253723 [Abstract] [Full Text] [Related]
13. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis. Zakaria EM, El-Maraghy NN, Ahmed AF, Ali AA, El-Bassossy HM. Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun 15; 390(6):621-631. PubMed ID: 28224182 [Abstract] [Full Text] [Related]
14. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H. Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):56-65. PubMed ID: 23896433 [Abstract] [Full Text] [Related]
15. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms. Abd El Motteleb DM, Abd El Aleem DI. Clin Exp Pharmacol Physiol; 2017 Apr 05; 44(4):509-521. PubMed ID: 28079268 [Abstract] [Full Text] [Related]
16. Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation. Olatunji OJ, Chen H, Zhou Y. Biomed Pharmacother; 2018 Jun 05; 102():1145-1151. PubMed ID: 29710532 [Abstract] [Full Text] [Related]
17. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway. Sutariya B, Saraf M. J Ethnopharmacol; 2017 Feb 23; 198():432-443. PubMed ID: 28111218 [Abstract] [Full Text] [Related]
18. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Maheshwari RA, Balaraman R, Sen AK, Seth AK. Indian J Pharmacol; 2014 Feb 23; 46(6):627-32. PubMed ID: 25538335 [Abstract] [Full Text] [Related]
19. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC, Liu IM. BMC Complement Altern Med; 2014 Mar 26; 14():110. PubMed ID: 24666993 [Abstract] [Full Text] [Related]
20. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ. J Ethnopharmacol; 2011 Dec 08; 138(3):731-6. PubMed ID: 22027446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]